United States Drugs for Acute Nasopharyngitis Market Report 2016

October 2016 | 108 pages | ID: U26CCF9D044EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for Acute Nasopharyngitis

Revenue, means the sales value of Drugs for Acute Nasopharyngitis

This report studies sales (consumption) of Drugs for Acute Nasopharyngitis in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Charleston Laboratories
• Cocrystal Pharma
• Neos Therapeutics
• Orbis Biosciences
• Vernalis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Acute Nasopharyngitis in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Drugs for Acute Nasopharyngitis Market Report 2016

1 DRUGS FOR ACUTE NASOPHARYNGITIS OVERVIEW

1.1 Product Overview and Scope of Drugs for Acute Nasopharyngitis
1.2 Classification of Drugs for Acute Nasopharyngitis
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Drugs for Acute Nasopharyngitis
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drugs for Acute Nasopharyngitis (2011-2021)
  1.4.1 United States Drugs for Acute Nasopharyngitis Sales and Growth Rate (2011-2021)
  1.4.2 United States Drugs for Acute Nasopharyngitis Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUGS FOR ACUTE NASOPHARYNGITIS COMPETITION BY MANUFACTURERS

2.1 United States Drugs for Acute Nasopharyngitis Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Acute Nasopharyngitis Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Acute Nasopharyngitis Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Acute Nasopharyngitis Market Competitive Situation and Trends
  2.4.1 Drugs for Acute Nasopharyngitis Market Concentration Rate
  2.4.2 Drugs for Acute Nasopharyngitis Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUGS FOR ACUTE NASOPHARYNGITIS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Drugs for Acute Nasopharyngitis Sales and Market Share by Type (2011-2016)
3.2 United States Drugs for Acute Nasopharyngitis Revenue and Market Share by Type (2011-2016)
3.3 United States Drugs for Acute Nasopharyngitis Price by Type (2011-2016)
3.4 United States Drugs for Acute Nasopharyngitis Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRUGS FOR ACUTE NASOPHARYNGITIS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Drugs for Acute Nasopharyngitis Sales and Market Share by Application (2011-2016)
4.2 United States Drugs for Acute Nasopharyngitis Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRUGS FOR ACUTE NASOPHARYNGITIS MANUFACTURERS PROFILES/ANALYSIS

5.1 Charleston Laboratories
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drugs for Acute Nasopharyngitis Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Charleston Laboratories Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Cocrystal Pharma
  5.2.2 Drugs for Acute Nasopharyngitis Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Cocrystal Pharma Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Neos Therapeutics
  5.3.2 Drugs for Acute Nasopharyngitis Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Neos Therapeutics Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Orbis Biosciences
  5.4.2 Drugs for Acute Nasopharyngitis Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Orbis Biosciences Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Vernalis
  5.5.2 Drugs for Acute Nasopharyngitis Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Vernalis Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview

6 DRUGS FOR ACUTE NASOPHARYNGITIS MANUFACTURING COST ANALYSIS

6.1 Drugs for Acute Nasopharyngitis Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drugs for Acute Nasopharyngitis

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Drugs for Acute Nasopharyngitis Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drugs for Acute Nasopharyngitis Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRUGS FOR ACUTE NASOPHARYNGITIS MARKET FORECAST (2016-2021)

10.1 United States Drugs for Acute Nasopharyngitis Sales, Revenue Forecast (2016-2021)
10.2 United States Drugs for Acute Nasopharyngitis Sales Forecast by Type (2016-2021)
10.3 United States Drugs for Acute Nasopharyngitis Sales Forecast by Application (2016-2021)
10.4 Drugs for Acute Nasopharyngitis Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Acute Nasopharyngitis
Table Classification of Drugs for Acute Nasopharyngitis
Figure United States Sales Market Share of Drugs for Acute Nasopharyngitis by Type in 2015
Table Application of Drugs for Acute Nasopharyngitis
Figure United States Sales Market Share of Drugs for Acute Nasopharyngitis by Application in 2015
Figure United States Drugs for Acute Nasopharyngitis Sales and Growth Rate (2011-2021)
Figure United States Drugs for Acute Nasopharyngitis Revenue and Growth Rate (2011-2021)
Table United States Drugs for Acute Nasopharyngitis Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Acute Nasopharyngitis Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Acute Nasopharyngitis Sales Share by Manufacturers
Figure 2016 Drugs for Acute Nasopharyngitis Sales Share by Manufacturers
Table United States Drugs for Acute Nasopharyngitis Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Acute Nasopharyngitis Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Acute Nasopharyngitis Revenue Share by Manufacturers
Table 2016 United States Drugs for Acute Nasopharyngitis Revenue Share by Manufacturers
Table United States Market Drugs for Acute Nasopharyngitis Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Acute Nasopharyngitis Average Price of Key Manufacturers in 2015
Figure Drugs for Acute Nasopharyngitis Market Share of Top 3 Manufacturers
Figure Drugs for Acute Nasopharyngitis Market Share of Top 5 Manufacturers
Table United States Drugs for Acute Nasopharyngitis Sales by Type (2011-2016)
Table United States Drugs for Acute Nasopharyngitis Sales Share by Type (2011-2016)
Figure United States Drugs for Acute Nasopharyngitis Sales Market Share by Type in 2015
Table United States Drugs for Acute Nasopharyngitis Revenue and Market Share by Type (2011-2016)
Table United States Drugs for Acute Nasopharyngitis Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Acute Nasopharyngitis by Type (2011-2016)
Table United States Drugs for Acute Nasopharyngitis Price by Type (2011-2016)
Figure United States Drugs for Acute Nasopharyngitis Sales Growth Rate by Type (2011-2016)
Table United States Drugs for Acute Nasopharyngitis Sales by Application (2011-2016)
Table United States Drugs for Acute Nasopharyngitis Sales Market Share by Application (2011-2016)
Figure United States Drugs for Acute Nasopharyngitis Sales Market Share by Application in 2015
Table United States Drugs for Acute Nasopharyngitis Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Acute Nasopharyngitis Sales Growth Rate by Application (2011-2016)
Table Charleston Laboratories Basic Information List
Table Charleston Laboratories Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Charleston Laboratories Drugs for Acute Nasopharyngitis Sales Market Share (2011-2016)
Table Cocrystal Pharma Basic Information List
Table Cocrystal Pharma Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cocrystal Pharma Drugs for Acute Nasopharyngitis Sales Market Share (2011-2016)
Table Neos Therapeutics Basic Information List
Table Neos Therapeutics Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neos Therapeutics Drugs for Acute Nasopharyngitis Sales Market Share (2011-2016)
Table Orbis Biosciences Basic Information List
Table Orbis Biosciences Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orbis Biosciences Drugs for Acute Nasopharyngitis Sales Market Share (2011-2016)
Table Vernalis Basic Information List
Table Vernalis Drugs for Acute Nasopharyngitis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vernalis Drugs for Acute Nasopharyngitis Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Acute Nasopharyngitis
Figure Manufacturing Process Analysis of Drugs for Acute Nasopharyngitis
Figure Drugs for Acute Nasopharyngitis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Acute Nasopharyngitis Major Manufacturers in 2015
Table Major Buyers of Drugs for Acute Nasopharyngitis
Table Distributors/Traders List
Figure United States Drugs for Acute Nasopharyngitis Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs for Acute Nasopharyngitis Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs for Acute Nasopharyngitis Production Forecast by Type (2016-2021)
Table United States Drugs for Acute Nasopharyngitis Consumption Forecast by Application (2016-2021)